Impact of patient characteristics on the risk of influenza/ILI-related complications

BMC Health Services Research

Volumn 1, Issue , 2001, Pages 1-10

  Irwin, Debra E ^a   Weatherby, Lisa B ^a   Huang, Wen Yi ^b,c   Rosenberg, Daniel M ^d   Cook, Suzanne F ^b   Walker, Alexander M ^a  

^a Ingenix Inc   (United States)

^b GLAXOSMITHKLINE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMANTADINE; ANTIBIOTIC AGENT; ANTITUSSIVE AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DECONGESTIVE AGENT; EXPECTORANT AGENT; IBUPROFEN; IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; IPRATROPIUM BROMIDE; MUCOLYTIC AGENT; NAPROXEN; PARACETAMOL; RIMANTADINE; STEROID; THEOPHYLLINE;

ARTICLE; AUTOMATION; CHRONIC LUNG DISEASE; COMORBIDITY; DATA BASE; DIABETES MELLITUS; DRUG COST; FLU LIKE SYNDROME; FOLLOW UP; HEALTH CARE COST; HEALTH SERVICE; HEART DISEASE; HOSPITALIZATION; HUMAN; INFECTION RISK; INFLUENZA; INSURANCE; LENGTH OF STAY; MALIGNANT NEOPLASTIC DISEASE; PREDICTION; REIMBURSEMENT; RESPIRATORY TRACT DISEASE;

EID: 3042814444     PISSN: 14726963     EISSN: None     Source Type: Journal    
DOI: 10.1186/1472-6963-1-1     Document Type: Article

References (19)

1. Simonsen L, Clarke MJ, Williamson GD, Stroup D, Arden NH, Schonberger LB: The Impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health 1997, 87:1944-1950
2. Barker WH: Excess pneumonia and influenza-associated hospitalization during influenza epidemics in the U.S., 1970-1978. Am J Public Health 1986, 76:761-765
3. Centers for Disease Control and Prevention: Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2000, 49(No. RR-3):
4. Centers for Disease Control and Prevention: Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1998, 47(RR-6):1-26
5. Perotta DM, Decker M, Glezen WP: Acute respiratory disease hospitalizations as a measure of impact of epidemic influenza: Am J Epidemiol 1985, 122:468-476
6. Nichol K: Complications of influenza and benefits of vaccination. Vaccine 1999, 17:S47-S52
7. McBean A, Babish J, Warren J: The impact and cost of influenza in the elderly. Arch Intern Med 1993, 153:2105-2111
8. International Classification of Diseases, 9th Revision, Clinical Modification. 5th edition. Medicode Publications, Salt Lake City UT, 1997
9. American Medical Association: Physicians' Current Procedural Terminology: CPT 97. American Medical Association, Chicago IL, 1997
10. HCPCS: Medicare's National Level II Codes. Medicode Publications, Salt Lake City UT, 1997
11. AHFS 97: Drug Information. American Hospital Formulary Service, Bethesda MD, 1997
12. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group: Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. Lancet 1998, 352:1877-81
13. Mullooly J, Bennett M, Hornbrook M, Barker W, Williams W, Patriarca P, Rhodes P: Influenza vaccination programs for elderly persons: cost effectiveness in a health maintenance organization. Ann Intern Med 1994, 121:947-952
14. Nichol K: Complications of influenza and benefits of vaccination. Vaccine 1999, 17:S47-S52
15. Postma M, Bos J, van Gennep M, Jager J, Baltussen R, Sprenger M: Economic evaluation of influenza vaccination. Assessment for the Netherlands. Pharmacoeconomics 1999, 16 Suppl 1:33-40
16. Nichol K, Margolis K, Wuorenma J, Von Sternberg T: The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. NEJM 1994, 331:778-784
17. World Health Organization. Weekly Epidemiology Record 1998, 73(7):41-48
18. Centers for Disease Control and Prevention: Surveillance for Influenza - United States, 1994-95, 1995-96, and 1996-97 Seasons. MMWR 2000, 49(SS03):13-28
19. Mandell G, Bennett J, Dolin R: Principles and Practice of Infectious Disease 4th Edition, Churchill Livingstone 1995